Kentaro Oka

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot et al. · Nature Medicine · 2022 · 427 citations · Full text

Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis

Mao Hagihara, Yasutoshi Kuroki, Tadashi Ariyoshi et al. · iScience · 2019 · 153 citations · Full text

Oral microbiome alterations of healthy volunteers with proton pump inhibitor

Tsuyoshi Mishiro, Kentaro Oka, Yasutoshi Kuroki et al. · Journal of Gastroenterology and Hepatology · 2017 · 92 citations

Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain

Timothy Woo, Kentaro Oka, Motomichi Takahashi et al. · Journal of Medical Microbiology · 2011 · 91 citations

Probiotics, Culture Medium, Drug Resistance +16

Molecular and Microbiological Characterization of Clostridium difficile Isolates from Single, Relapse, and Reinfection Cases

Kentaro Oka, Takako Osaki, Tomoko Hanawa et al. · Journal of Clinical Microbiology · 2011 · 82 citations · Full text

Medical Microbiology, Antimicrobial Susceptibility, Microbial Disease +13